摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-1-((2S,5R)-5-Bromo-2,6,6-trimethyl-tetrahydro-pyran-2-yl)-ethane-1,2-diol | 304466-04-4

中文名称
——
中文别名
——
英文名称
(R)-1-((2S,5R)-5-Bromo-2,6,6-trimethyl-tetrahydro-pyran-2-yl)-ethane-1,2-diol
英文别名
——
(R)-1-((2S,5R)-5-Bromo-2,6,6-trimethyl-tetrahydro-pyran-2-yl)-ethane-1,2-diol化学式
CAS
304466-04-4
化学式
C10H19BrO3
mdl
——
分子量
267.163
InChiKey
GGEACOQAMDYKOY-MRTMQBJTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.45
  • 重原子数:
    14.0
  • 可旋转键数:
    2.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    49.69
  • 氢给体数:
    2.0
  • 氢受体数:
    3.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Total Synthesis of Thyrsiferyl 23-Acetate, a Specific Inhibitor of Protein Phosphatase 2A and an Anti-Leukemic Inducer of Apoptosis
    摘要:
    A convergent synthetic entry to the squalenoid polyether system has been developed and applied to the biologically active marine natural products thyrsiferyl 23-acetate (la), thyrsiferol (Ib), thyrsiferyl 18-acetate (Ic), and thyrsiferyl 18,23-diacetate (Id). This involved the separate construction of two advanced intermediates representing the C1-C15 (4) and C16-C24 (5) domains, followed by their organochromium-mediated coupling, installation of the tertiary alcohol at C15, and manipulation of the C18 and C23 acetate moieties. The C1-C15 (4) intermediate containing the three tetrahydropyranyl rings (A-B-C) was derived from two preconstructed tetrahydropyran-containing units representing the functionalized A (C2-C6) and C (C10-C14) rings (6 and 7, respectively). The bromotetrahydropyranyl A ring was obtained via bromoetherification of the hydroxyalkene 16, which was synthesized from (2R,3R)-epoxy geraniol. The C ring was stereoselectively constructed by acid-catalyzed opening of the hydroxy epoxide 32, derived from D-glutamic acid. Intermediates 6 and 7 were-joined using organochromium conditions, and ketone and hydroxyl functionalities were installed at carbons:7 and 11, respectively. Closure of the B ring was accomplished stereoselectively by formation of species derived from a C7, C11 keto-alcohol and in situ reduction of a tetrahydropyranyl oxonium. The complementary tetrahydrofuran D (C19-C22) ring was obtained from a geraniol-derived tertiary hydroxy alkene (44) via a stereoselective Re(VII)-induced syn-oxidative cyclization. The side chain appended to the D ring was elaborated into trans-alkenyl iodide 5 under Takai reaction conditions. CrCl2-mediated coupling of aldehyde 4 containing the secondary bromide at C3 of the natural products, with iodide 5 bearing acetate moieties at C18 and C23, installed the C15-C16 carbon-carbon bond. The resultant C15 allylic carbinol was converted into an cr,P-saturated ketone, and the final methyl group was added stereoselectively using methylmagnesium bromide. Saponification of the C18 acetate yielded la, whereas cleavage of both C18 and C23 acetates gave the triol Ib. This modular entry into the squalenoid-polyether system may facilitate further evaluation of the antileukemic, apoptosis-inducing, protein serine/threonine phosphatase 2A inhibitory and anti-multidrug resistance activities of the thyrsiferol-derived natural products.
    DOI:
    10.1021/ja000001r
  • 作为产物:
    描述:
    [(2R)-2-benzoyloxy-2-[(2S,5R)-5-bromo-2,6,6-trimethyloxan-2-yl]ethyl] benzoatepotassium carbonate 作用下, 以 甲醇 为溶剂, 反应 2.0h, 以86%的产率得到(R)-1-((2S,5R)-5-Bromo-2,6,6-trimethyl-tetrahydro-pyran-2-yl)-ethane-1,2-diol
    参考文献:
    名称:
    Total Synthesis of Thyrsiferyl 23-Acetate, a Specific Inhibitor of Protein Phosphatase 2A and an Anti-Leukemic Inducer of Apoptosis
    摘要:
    A convergent synthetic entry to the squalenoid polyether system has been developed and applied to the biologically active marine natural products thyrsiferyl 23-acetate (la), thyrsiferol (Ib), thyrsiferyl 18-acetate (Ic), and thyrsiferyl 18,23-diacetate (Id). This involved the separate construction of two advanced intermediates representing the C1-C15 (4) and C16-C24 (5) domains, followed by their organochromium-mediated coupling, installation of the tertiary alcohol at C15, and manipulation of the C18 and C23 acetate moieties. The C1-C15 (4) intermediate containing the three tetrahydropyranyl rings (A-B-C) was derived from two preconstructed tetrahydropyran-containing units representing the functionalized A (C2-C6) and C (C10-C14) rings (6 and 7, respectively). The bromotetrahydropyranyl A ring was obtained via bromoetherification of the hydroxyalkene 16, which was synthesized from (2R,3R)-epoxy geraniol. The C ring was stereoselectively constructed by acid-catalyzed opening of the hydroxy epoxide 32, derived from D-glutamic acid. Intermediates 6 and 7 were-joined using organochromium conditions, and ketone and hydroxyl functionalities were installed at carbons:7 and 11, respectively. Closure of the B ring was accomplished stereoselectively by formation of species derived from a C7, C11 keto-alcohol and in situ reduction of a tetrahydropyranyl oxonium. The complementary tetrahydrofuran D (C19-C22) ring was obtained from a geraniol-derived tertiary hydroxy alkene (44) via a stereoselective Re(VII)-induced syn-oxidative cyclization. The side chain appended to the D ring was elaborated into trans-alkenyl iodide 5 under Takai reaction conditions. CrCl2-mediated coupling of aldehyde 4 containing the secondary bromide at C3 of the natural products, with iodide 5 bearing acetate moieties at C18 and C23, installed the C15-C16 carbon-carbon bond. The resultant C15 allylic carbinol was converted into an cr,P-saturated ketone, and the final methyl group was added stereoselectively using methylmagnesium bromide. Saponification of the C18 acetate yielded la, whereas cleavage of both C18 and C23 acetates gave the triol Ib. This modular entry into the squalenoid-polyether system may facilitate further evaluation of the antileukemic, apoptosis-inducing, protein serine/threonine phosphatase 2A inhibitory and anti-multidrug resistance activities of the thyrsiferol-derived natural products.
    DOI:
    10.1021/ja000001r
点击查看最新优质反应信息

同类化合物

顺式-4-氨基-四氢呋喃-3-醇 顺-4-(氨基甲基)氧杂-3-醇 钨,三氯羰基二(四氢呋喃)- 苏-4-羟基-5-甲氧基-3-甲基四氢呋喃-3-甲醇 艾瑞布林中间体 甲基噁丙环聚合噁丙环,醚2,4,7,9-四甲基-5-癸炔-4,7-二醇(2:1) 甲基[(氧杂戊-3-基)甲基]胺盐酸盐 甲基NA酸酐 甲基3-脱氧-D-赤式-呋喃戊糖苷 甲基2,5-脱水-3-脱氧-4-O-甲基戊酮酸酯 甲基-2,3-二脱氧-3-氟-5-O-新戊酰基-alpha-D-赤式戊呋喃糖苷 甲基(2S,5R)-5-(氯乙酰基)四氢-2-呋喃羧酸酯 甲基(2R,5S)-5-(氯乙酰基)四氢-2-呋喃羧酸酯 甲基(1S)-3-硝基-7-氧杂双环[2.2.1]庚烷-2-羧酸酯 球二孢菌素 环戊二烯基二羰基(四氢呋喃)铁(II)四氟硼酸 环十二碳六烯并[c]呋喃-1,1,3,3-四甲腈,十二氢- 环丁基-n-((四氢呋喃-2-基)甲基)甲胺 溴化镧水合物 溴三羰基(四氢呋喃)r(I)二聚体 氯化镁四氢呋喃聚合物 氯化锌四氢呋喃配合物(1:2) 氯化铪(IV)四氢呋喃络合物 氯化钴四氢呋喃聚合物 氯化钪四氢呋喃配合物 氨基甲酸,四氢-3,5-二甲基-3-呋喃基酯 正丁基(3-氰基氧杂-3-基)氨基甲酸酯 四氯化铀(四氢呋喃)3 四氢糠醇氧化钡 四氢糠基乙烯基醚 四氢呋喃钠 四氢呋喃钛酸钡(IV) 四氢呋喃溴化镁 四氢呋喃基-2-乙基酮 四氢呋喃-3-羰酰氯 四氢呋喃-3-磺酰氯 四氢呋喃-3-硼酸 四氢呋喃-3-乙酸 四氢呋喃-3,3,4,4-D4 四氢呋喃-2-羧酸-(2-乙基己基酯) 四氢呋喃-2-甲酸 (3-甲基氨基丙基)酰胺 四氢呋喃-2'-基醚 四氢-N-(3-氰基丙基)-N-甲基呋喃甲酰胺 四氢-N,N-二甲基-2-呋喃甲胺 四氢-5-甲基-5-(4-甲基-3-戊烯基)-2-呋喃醇 四氢-3-甲基-3-羟基呋喃 四氢-3-甲基-3-呋喃羧酸 四氢-3-呋喃羧酰胺 四氢-3-呋喃甲酰肼 四氢-3-呋喃基氰基乙酸酯